Biostimulators Explained: PLLA, CaHA and PCL for Collagen Regeneration
· 2 min read · Harley Street Pharma Editorial
Collagen loss is one of the defining features of skin ageing, beginning in our twenties and accelerating with menopause, sun damage and significant weight loss. Biostimulators are designed to tackle it at the source, by prompting the body to build new collagen of its own.
What is a biostimulator?
A biostimulator is an injectable that triggers a controlled response in the tissue, leading fibroblasts to produce new collagen over the following weeks and months. Unlike a traditional HA filler, the main result is not the product itself but the body’s response to it. Results therefore build gradually and can be long-lasting.
The main types
Poly-L-lactic acid (PLLA)
PLLA is a biocompatible, biodegradable polymer. Reconstituted and injected, it stimulates gradual collagen production, usually over a course of treatments. Sculptra is the best-known PLLA product. Browse PLLA & collagen stimulators.
Calcium hydroxylapatite (CaHA)
CaHA microspheres in a gel carrier provide some immediate support, then stimulate collagen as the gel is absorbed. Diluted or hyperdiluted, CaHA is also widely used for skin quality and laxity on the face and body. Radiesse is the leading example. See CaHA products.
Polycaprolactone (PCL)
PCL microspheres in a carrier gel offer immediate correction with collagen stimulation, and different formulations are designed for different durations. Ellansé is the most familiar PCL product. See PCL products.
Biostimulators match three of the biggest patient demands: natural results, long-lasting improvement and regeneration rather than camouflage. They are particularly relevant for patients after significant weight loss, including those on GLP-1 medicines, and for perimenopausal patients noticing a sudden change in skin firmness.
Fillers give you the result. Biostimulators help the body build it.
Safety and technique
Biostimulators are not interchangeable with HA fillers. Most cannot be dissolved with hyaluronidase, so injector training, correct dilution, depth and patient selection are essential. Always follow the manufacturer’s instructions and approved indications.
Immortality is not on the horizon. But for the first time, therapies designed to slow or reverse parts of ageing are being tested in people. Here is what is real, what is hype and what it means for aesthetics.
In 2026 a therapy built on David Sinclair's epigenetic reprogramming research was given to people for the first time, in an attempt to restore sight lost to glaucoma and optic nerve stroke. Here is what the early data shows.
Oral GLP-1 tablets, higher-dose injections and millions of new patients. How the GLP-1 revolution moved on in 2026, and why it is reshaping aesthetic practice.